Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Sellers have arrived
View:
Post by Minty_33 on Sep 22, 2020 10:44am

Sellers have arrived

And zero volume. Just goes to show the level of confidence that the market places in Mr. Gagnon's ability to execute on the exciting initiatives. Perhaps it's time for a change at the helm and in the non-existant IR department.
Comment by ZoranSto on Sep 22, 2020 10:56am
I would have to agree, this is rediculous. After so many positive recent news releases and such huge potential any other stock would still be climbing. Lets wait and see what happens in the next 30 to 40 days and see if these sellers regret selling at 66 cents.....i personally hope so...i haven't sold any shares
Comment by Ciao on Sep 22, 2020 11:39am
Yes it's at a ridiculous valuation. The recent correction in the share price (30% drop from high) to .65 level removes any valuation attributed to the progress in their COVID work noted in their Aug. 18 NR and the great Q2 financials announced on Aug. 20. If one is looking for support on the share price, lets put a EPS est. of .05 for the current year and we are trading at So once again ...more  
Comment by EbbFlow88 on Sep 22, 2020 12:37pm
It amazes me how quick everyone is to flip flop on Gilles based on the stock price on such short term intervals.  It's the nature of investing in microcaps with extremely thin volumes. Everyone here knows the potential of Ceapro and Gilles has done nothing less than bring us closer and closer to that goal.  Sales are at all time highs, we are profitable again and have had positive ...more  
Comment by Stinzo on Sep 22, 2020 2:21pm
ultimately, Gilles just delivered a presentation to attract investors and update current investors providing some positive news which the market did not appreciate. The overall market is down, then again biotech is the one sector money is flowing into in large quantities.  I continue being invested because I still beleive in its success however even after reading all the press releases and ...more  
Comment by Ciao on Sep 22, 2020 2:35pm
" Gilles/CZO purchased the equipment in Germany and in the States without any partners just so that they can carry on at their own pace, with their own agenda." IMHO, I don't see an issue with this.  CZO knows what equipment to purchase and how to tweak it, they have enough capital to do it alone as well.  The input from any potential customer would be the capacity of ...more  
Comment by trek01 on Sep 22, 2020 12:35pm
Minty, many people bought tons of shares sub 0.20. When the overall market is flashing red I'm not surprised that someone is selling.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities